Literature DB >> 16705171

Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms.

Patrick Bryant1, Qingxia Zheng, Kevin Pumiglia.   

Abstract

Endothelial cell proliferation is a critical step in angiogenesis and requires a coordinated response to soluble growth factors and the extracellular matrix. As focal adhesion kinase (FAK) integrates signals from both adhesion events and growth factor stimulation, we investigated its role in endothelial cell proliferation. Expression of a dominant-negative FAK protein, FAK-related nonkinase (FRNK), impaired phosphorylation of FAK and blocked DNA synthesis in response to multiple angiogenic stimuli. These results coincided with elevated cyclin-dependent kinase inhibitors (CDKIs) p21/Cip and p27/Kip, as a consequence of impaired degradation. FRNK inhibited the expression of Skp2, an F-box protein that targets CDKIs, by inhibiting mitogen-induced mRNA. The FAK-regulated degradation of p27/Kip was Skp2 dependent, while levels of p21/Cip were regulated independent of Skp2. Skp2 is required for endothelial cell proliferation as a consequence of degrading p27. Finally, knockdown of both p21 and p27 in FRNK-expressing cells completely restored mitogen-induced endothelial cell proliferation. These data demonstrate a critical role for FAK in the regulation of CDKIs through two independent mechanisms: Skp2 dependent and Skp2 independent. They also provide important insights into the requirement of focal adhesion kinase for normal vascular development and reveal novel regulatory control points for angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705171      PMCID: PMC1489078          DOI: 10.1128/MCB.01612-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  87 in total

Review 1.  How proteolysis drives the cell cycle.

Authors:  R W King; R J Deshaies; J M Peters; M W Kirschner
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

2.  Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway.

Authors:  K M Pumiglia; S J Decker
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

3.  Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes.

Authors:  J DeGregori; T Kowalik; J R Nevins
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

4.  Anchorage-dependent transcription of the cyclin A gene.

Authors:  A Schulze; K Zerfass-Thome; J Bergès; S Middendorp; P Jansen-Dürr; B Henglein
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

5.  Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation.

Authors:  A P Gilmore; L H Romer
Journal:  Mol Biol Cell       Date:  1996-08       Impact factor: 4.138

Review 6.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

7.  A mechanism for regulation of the adhesion-associated proteintyrosine kinase pp125FAK.

Authors:  A Richardson; T Parsons
Journal:  Nature       Date:  1996-04-11       Impact factor: 49.962

8.  Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice.

Authors:  D Ilić; Y Furuta; S Kanazawa; N Takeda; K Sobue; N Nakatsuji; S Nomura; J Fujimoto; M Okada; T Yamamoto
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

9.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

Authors:  M Pagano; S W Tam; A M Theodoras; P Beer-Romero; G Del Sal; V Chau; P R Yew; G F Draetta; M Rolfe
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

10.  Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.

Authors:  X Zhu; M Ohtsubo; R M Böhmer; J M Roberts; R K Assoian
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

View more
  32 in total

Review 1.  A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy.

Authors:  Pravin T P Kaumaya
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation.

Authors:  Ssang-Taek Lim; Xiao Lei Chen; Yangmi Lim; Dan A Hanson; Thanh-Trang Vo; Kyle Howerton; Nicholas Larocque; Susan J Fisher; David D Schlaepfer; Dusko Ilic
Journal:  Mol Cell       Date:  2008-01-18       Impact factor: 17.970

3.  Cyclic mechanical stretch decreases cell migration by inhibiting phosphatidylinositol 3-kinase- and focal adhesion kinase-mediated JNK1 activation.

Authors:  Leena P Desai; Steven R White; Christopher M Waters
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

4.  AMPKα2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells.

Authors:  Ping Song; Shuangxi Wang; Chaoyong He; Shaobin Wang; Bin Liang; Benoit Viollet; Ming-Hui Zou
Journal:  Circ Res       Date:  2011-10-06       Impact factor: 17.367

5.  FAK is required for Schwann cell spreading on immature basal lamina to coordinate the radial sorting of peripheral axons with myelination.

Authors:  Matthew Grove; Peter J Brophy
Journal:  J Neurosci       Date:  2014-10-01       Impact factor: 6.167

6.  Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer.

Authors:  Frank Aboubakar Nana; Marylène Lecocq; Maha Zohra Ladjemi; Bruno Detry; Sébastien Dupasquier; Olivier Feron; Pierre P Massion; Yves Sibille; Charles Pilette; Sebahat Ocak
Journal:  Mol Cancer Ther       Date:  2018-10-23       Impact factor: 6.261

Review 7.  FERM control of FAK function: implications for cancer therapy.

Authors:  Ssang-Taek Lim; David Mikolon; Dwayne G Stupack; David D Schlaepfer
Journal:  Cell Cycle       Date:  2008-05-29       Impact factor: 4.534

8.  Loss of anchorage in checkpoint-deficient cells increases genomic instability and promotes oncogenic transformation.

Authors:  Catherine A Cremona; Alison C Lloyd
Journal:  J Cell Sci       Date:  2009-08-18       Impact factor: 5.285

9.  Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.

Authors:  Angélica M Santos; Jason Jung; Nazneen Aziz; Joseph L Kissil; Ellen Puré
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

10.  RHOA-FAK is a required signaling axis for the maintenance of KRAS-driven lung adenocarcinomas.

Authors:  Georgia Konstantinidou; Giorgio Ramadori; Francesca Torti; Kim Kangasniemi; Rachel E Ramirez; Yiran Cai; Carmen Behrens; Michael T Dellinger; Rolf A Brekken; Ignacio I Wistuba; Adriana Heguy; Julie Teruya-Feldstein; Pier Paolo Scaglioni
Journal:  Cancer Discov       Date:  2013-01-28       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.